MAPT and Alzheimer disease: This APPSwe-expressing mouse model was chosen because it displays cerebral Aβ deposition and tau modifications, synaptic dysfunction, gliosis, age-dependent memory deficits along with ocular Aβ and tau pathologies [5, 6, 9, 58], thus representing an ideal model to study the AD-associated changes, both in the retina and in the brain.